Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Sabra Healthcare reported revenue of $189.15 million for the quarter ended June 2025, reflecting a 7.4% increase year-over-year and a surprise of +1.98% over the Zacks Consensus Estimate of $185.47 million [1] - The company's EPS for the quarter was $0.38, significantly higher than $0.10 in the same quarter last year, with an EPS surprise of +2.7% compared to the consensus estimate of $0.37 [1] Financial Performance Metrics - Interest and other income reached $10.34 million, exceeding the estimated $10.03 million, marking a +13.6% change year-over-year [4] - Rental and related revenues were reported at $99.82 million, surpassing the estimated $95.9 million, with a +0.7% change compared to the previous year [4] - Resident fees and services generated $78.99 million, slightly above the $78.6 million estimate, representing a +16.3% year-over-year increase [4] - Net Earnings Per Share (Diluted) was $0.27, compared to the average estimate of $0.17, indicating a positive performance [4] Stock Performance - Over the past month, Sabra's shares have returned -1.8%, contrasting with the Zacks S&P 500 composite's +0.6% change [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]